GE Healthcare and Roche partnered to develop a digital clinical decision support solution, focusing on products that accelerate and improve personalized cancer and critical care treatments, the companies said Monday.
As part of the agreement, the companies will work to build an analytics-enabled, digital platform that offers workflow solutions and apps supporting clinical decisions. The platform will allow integration and analysis of in-vivo and in-vitro data, patient records, medical best practice, real-time monitoring and the latest research outcomes.
"This is the first time that two major players in healthcare have combined advanced analytics with in-vivo and in-vitro diagnostics to this degree. We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients and the healthcare industry," said Kieran Murphy, president and CEO of GE Healthcare.
More articles on health IT:
Medical device supplier DJO Global notifies Las Vegas hospital of lost patient data